바이오인

 

 

 

This report analyzes the impact of the biopharmaceutical sector on the U.S. economy at the national, state, and metropolitan statistical area (MSA) levels.  This analysis reflects the activity associated with American biopharmaceutical companies with respect to employment levels, wages and personal taxes, and economic impact (as measured by dollar contribution to GDP and dollar output).  This study also considers investment in R&D and ongoing clinical trials.  The report concentrates on the economic activity associated with biopharmaceutical companies in 2006 and analyzes the s in economic activity between 1996 and 2006, given that 2006 was the most recent year for which complete data was available for the analyses conducted.